We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 878

U.S.-Mexico-Canada Agreement: Business Insights on Intellectual Property Issues
  • Borden Ladner Gervais LLP
  • Canada
  • October 22 2018

On September 30, 2018, Canada, the United States and Mexico reached an agreement on what is essentially a revised NAFTA. The new agreement will be


Intellectual Property Weekly Abstracts Bulletin Week of October 30, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • November 1 2017

The Ontario Superior Court of Justice granted the Defendants motion for summary judgment in respect of the Plaintiff’s claims of copyright


Expansion of Geographical Indications Under CETA Now in Effect in Canada
  • Borden Ladner Gervais LLP
  • Canada, European Union
  • October 23 2017

As of September 21, 2017, Canada has implemented a number of amendments to the Canadian Trade-marks Act related to the protection of geographical


Intellectual Property Weekly Abstracts Bulletin Week of October 16, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • October 18 2017

The Federal Court recently issued the public decision in the reference on the patent infringement finding and the section 8 damages finding between


Intellectual Property Weekly Abstracts Bulletin Week of October 9, 2017
  • Borden Ladner Gervais LLP
  • USA, Canada
  • October 16 2017

The Federal Court recently issued the public decision in the reference on the patent infringement finding and the section 8 damages finding between


Intellectual Property Weekly Abstracts Bulletin Week of October 9, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • October 11 2017

Dismissed motion for partial summary judgment upheld - Apotex unable to rely on section 73 of the Patent Act, as it existed in 1989, to void the


Intellectual Property Weekly Abstracts Bulletin Week of October 2, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • October 4 2017

This is an application pursuant to the Patented Medicines (Notice of Compliance) Regulations. The Court began by noting a related decision in which a


Intellectual Property Weekly Abstracts Bulletin Week of September 25, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • September 28 2017

FCA allows appeal regarding lack of utility finding in light of Supreme Court’s recent decision in Esomeprazole Bristol-Myers Squibb Canada Co. v


Certificates of Supplemental Protection
  • Borden Ladner Gervais LLP
  • Canada
  • September 22 2017

For the first time, as of September 21, 2017, Canada has a form of patent term restoration. This will restore part of a patent’s term in relation to


Intellectual Property Weekly Abstracts Bulletin Week of September 18, 2017
  • Borden Ladner Gervais LLP
  • USA, Canada
  • September 20 2017

In context of opposition, Registrar has jurisdiction to issue a "split" decision for accepted goods andor services under subsection 38(8) Les Marques